• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019冠状病毒病大流行对产毒素艰难梭菌感染的影响及其与多重耐药细菌感染的相关性

Impact of COVID-19 pandemic on toxinogenic Clostridioides difficile infections and correlation with multidrug-resistant bacterial infections.

作者信息

Torrini Luisa, Diaco Fabiana, Viscido Agnese, Sacco Federica, Sfara Germana, Compagnino Daniele Emanuele, Puggioni Gianluca, Coletti Monica, Antonelli Guido, Raponi Giammarco

机构信息

Department of Molecular Medicine, Sapienza University of Rome, Italy.

Department of Molecular Medicine, Sapienza University of Rome, Italy.

出版信息

Diagn Microbiol Infect Dis. 2025 Nov;113(3):117014. doi: 10.1016/j.diagmicrobio.2025.117014. Epub 2025 Jul 18.

DOI:10.1016/j.diagmicrobio.2025.117014
PMID:40714693
Abstract

Clostridioides difficile infection (CDI) is one of the most common healthcare-associated infections, contributing to significant morbidity and mortality, particularly in hospitalized patients. Its incidence is influenced by infection control measures, antimicrobial stewardship, and hospital hygiene protocols. The Coronavirus disease 2019 (COVID-19) pandemic led to the widespread adoption of stringent infection prevention strategies. These measures may have influenced the incidence of CDI. At the university hospital Policlinico Umberto I in Rome, we conducted a retrospective analysis of CDI cases across three periods: preCOVID-19, COVID-19 and postCOVID-19. Our findings revealed a statistically significant decrease in CDI cases during the COVID-19 period compared to the preCOVID-19 period, as well as in the postCOVID-19 period compared to the COVID-19 period. Additionally, we explored the potential association between CDI and multidrug-resistant organisms (MDRO). Our findings indicate a reduction in MDRO infections among patients with CDI in the COVID-19 and postCOVID-19 periods compared to the preCOVID-19 period. These results highlight the potential impact of infection control strategies on CDI incidence and suggest a possible relationship between CDI and MDRO infection. Further research is needed to assess the long-term effects of these measures and their implications for future infection prevention strategies.

摘要

艰难梭菌感染(CDI)是最常见的医疗保健相关感染之一,会导致严重的发病率和死亡率,尤其是在住院患者中。其发病率受感染控制措施、抗菌药物管理以及医院卫生规程的影响。2019年冠状病毒病(COVID-19)大流行导致广泛采用严格的感染预防策略。这些措施可能影响了CDI的发病率。在罗马的翁贝托一世综合医院,我们对三个时期的CDI病例进行了回顾性分析:COVID-19之前、COVID-19期间和COVID-19之后。我们的研究结果显示,与COVID-19之前的时期相比,COVID-19期间的CDI病例有统计学意义的下降,与COVID-19期间相比,COVID-19之后的时期也有下降。此外,我们探讨了CDI与多重耐药菌(MDRO)之间的潜在关联。我们的研究结果表明,与COVID-19之前的时期相比,COVID-19期间和COVID-19之后的时期CDI患者中的MDRO感染有所减少。这些结果突出了感染控制策略对CDI发病率的潜在影响,并表明CDI与MDRO感染之间可能存在关联。需要进一步研究来评估这些措施的长期影响及其对未来感染预防策略的意义。

相似文献

1
Impact of COVID-19 pandemic on toxinogenic Clostridioides difficile infections and correlation with multidrug-resistant bacterial infections.2019冠状病毒病大流行对产毒素艰难梭菌感染的影响及其与多重耐药细菌感染的相关性
Diagn Microbiol Infect Dis. 2025 Nov;113(3):117014. doi: 10.1016/j.diagmicrobio.2025.117014. Epub 2025 Jul 18.
2
Antibiotic Use and the Risk of Hospital-Onset Clostridioides Difficile Infection.抗生素使用与医院获得性艰难梭菌感染风险
JAMA Netw Open. 2025 Aug 1;8(8):e2525252. doi: 10.1001/jamanetworkopen.2025.25252.
3
The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature.在 2019 冠状病毒病大流行期间预防和控制耐多药生物体和耳念珠菌爆发的挑战:耐碳青霉烯鲍曼不动杆菌爆发报告和文献系统评价。
Antimicrob Resist Infect Control. 2022 Jan 21;11(1):12. doi: 10.1186/s13756-022-01052-8.
4
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
5
Importance of underlying mechanisms for interpreting relative risk of Clostridioides difficile infection among antibiotic-exposed patients in healthcare facilities.解读医疗机构中抗生素暴露患者艰难梭菌感染相对风险的潜在机制的重要性。
PLoS One. 2024 Aug 8;19(8):e0306622. doi: 10.1371/journal.pone.0306622. eCollection 2024.
6
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).粪便微生物移植治疗复发性艰难梭菌(艰难梭菌)。
Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871. doi: 10.1002/14651858.CD013871.pub2.
7
Prevention of endemic healthcare-associated Clostridium difficile infection: reviewing the evidence.预防地方性医疗保健相关艰难梭菌感染:回顾证据。
Am J Gastroenterol. 2010 Nov;105(11):2327-39; quiz 2340. doi: 10.1038/ajg.2010.254. Epub 2010 Jul 6.
8
Comparison of outpatient attendance, cardiovascular risk management and cardiovascular health across preCOVID-19, during and postCOVID-19 periods: a prospective cohort study.2019年新冠疫情前、疫情期间及疫情后门诊就诊情况、心血管风险管理及心血管健康状况的比较:一项前瞻性队列研究
BMJ Open. 2025 Jul 16;15(7):e092374. doi: 10.1136/bmjopen-2024-092374.
9
Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a Tertiary Hospital: A Retrospective Comparative Study.新型冠状病毒肺炎大流行对一家三级医院艰难梭菌感染率的影响:一项回顾性比较研究
Cureus. 2025 Jun 15;17(6):e86045. doi: 10.7759/cureus.86045. eCollection 2025 Jun.
10
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.